Gilead Sciences’ (GILD) “Neutral” Rating Reiterated at Robert W. Baird
Robert W. Baird restated their neutral rating on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a report published on Thursday, Benzinga reports. The firm currently has a $80.00 price objective on the biopharmaceutical company’s stock. A number of other research analysts have also weighed in on the company. Truist Financial lowered Gilead Sciences […]
More Stories
TMT Acquisition Corp (NASDAQ:TMTC) Short Interest Up 25.8% in September
TMT Acquisition Corp (NASDAQ:TMTC – Get Free Report) was the target of a significant growth in short interest in the...
Sound Group Inc. (NASDAQ:SOGP) Sees Significant Decrease in Short Interest
Sound Group Inc. (NASDAQ:SOGP – Get Free Report) saw a large decline in short interest in the month of September....
Safety Shot, Inc. (NASDAQ:SHOT) Short Interest Down 18.2% in September
Safety Shot, Inc. (NASDAQ:SHOT – Get Free Report) saw a large decline in short interest in the month of September....
Russel Metals Inc. (OTCMKTS:RUSMF) Short Interest Update
Russel Metals Inc. (OTCMKTS:RUSMF – Get Free Report) was the target of a large growth in short interest in September....
Petrus Resources Ltd. (OTCMKTS:PTRUF) Short Interest Update
Petrus Resources Ltd. (OTCMKTS:PTRUF – Get Free Report) saw a large increase in short interest during the month of September....
Short Interest in Pennon Group Plc (OTCMKTS:PEGRY) Declines By 14.6%
Pennon Group Plc (OTCMKTS:PEGRY – Get Free Report) was the target of a large drop in short interest during the...